Chinese-Made Instant Coffee, Tea Products Recalled in U.S.
Seven "Mr. Brown"-brand instant coffee and tea products, produced in China, are being recalled because they may be contaminated with the industrial chemical melamine, the U.S. Food and Drug Administration said Friday.
The FDA also said consumers shouldn't eat Chinese-made White Rabbit Creamy Candy, which New Zealand authorities have found contains high levels of melamine, the Bloomberg news service reported.
Melamine, used to make plastics, is at the center of a scandal in China involving contaminated baby-formula products. At least four Chinese infants have died, and tens of thousands more have been sickened from ingesting the milk-based products, which it's believed were deliberately contaminated to mask that they had been watered down.
According to a statement posted on the FDA Web site, the recalled adult coffee products, made by China's Shandong Duqing Inc., are:
- Mr. Brown Mandheling Blend Instant Coffee (3-in-1)
- Mr. Brown Arabica Instant Coffee (3-in-1)
- Mr. Brown Blue Mountain Blend Instant Coffee (3-in-1)
- Mr. Brown Caramel Macchiato Instant Coffee (3-in-1)
- Mr. Brown French Vanilla Instant Coffee (3-in-1)
- Mr. Brown Mandhling Blend instant Coffee (2-in-1)
- Mr. Brown Milk Tea (3-in-1)
No illnesses related to the candy, coffee, or tea products have been reported in the United States, Bloomberg cited the FDA as saying.
In related news, the government of Hong Kong said Friday it had detected traces of melamine in baby foods imported from China, according to the Associated Press. Melamine has been detected in products from 22 Chinese dairy firms, the wire service said.
The World Health Organization and UNICEF have issued a joint statement condemning baby-food makers that deliberately contaminate their products.
"Whilst any attempt to deceive the public in the area of food production and marketing is unacceptable, deliberate contamination of foods intended for consumption by vulnerable infants and young children is particularly deplorable," the statement read.
-----
CDC Notes Mild West Nile Season
The 2008 West Nile virus season is shaping up to be the mildest since 2001, the U.S. Centers for Disease Control and Prevention said Friday.
The 368 severe cases tallied as of Tuesday represented less than one-third of the 2007 total, the Associated Press reported.
Most cases of West Nile are reported in August and September. The CDC said it wasn't clear why this season was on track to be so mild. Seven years ago, the last time so few severe cases were reported, the virus was just emerging in the United States and had only been identified in 10 states, the AP said.
Only about one in five people bitten by a West Nile infected mosquito becomes sick, and only about one in 150 contracts severe symptoms. These can include neck stiffness, disorientation, coma, and paralysis.
-----
U.S. Halts Chelation Study Enrollment
The U.S. government has stopped enrolling participants in the largest alternative medicine study it's ever funded to assess whether candidates were properly informed of the potential risks, the Associated Press reported Friday.
More than 1,500 people who had survived a heart attack had been enrolled in the $30 million study of chelation, a controversial method most often used as a remedy for lead poisoning. Despite the halt to new enrollees, existing participants are still being treated.
The study is meant to test the use of high doses of vitamins, minerals, and chelation -- a therapy that involves injection of a drug (disodium EDTA) that proponents claim helps rid the body of calcium-causing plaque that's built up in artery walls. The therapy hasn't been proven safe or effective in treating heart disease.
At least two of the participants have died, although the study's lead physician denied the deaths were related to the therapy.
"We think we have a safe and ethical trial and we're protecting our patients," the AP quoted Dr. Gervasio Lamas of the University of Miami as saying.
Lamas couldn't say precisely how many study enrollees had died. He also conceded that some participating physicians who had been disciplined by state boards or who had criminal records had been asked to withdraw from the study, the wire service said.
Study critics said the research, approved in 2002, represented a conflict of interest for more than half of the physicians involved, since they made money by selling chelation treatments to patients, the AP reported.
-----
Standardized Color Plan for Hospital Wristbands Faces Hurdles
A new standardized system for color-coded wristbands in hospitals to prevent potentially dangerous mistakes is essential to patient safety, proponents say, but others fear they may compromise patient privacy, The New York Times reported.
The movement to standardize color coding of the hospital bands gathered steam, in part, because of a 2005 Pennsylvania case where a patient nearly died when a nurse mistakenly used an incorrect band. The plan is to have the wristbands designate patient conditions so treatment can be checked: Purple, or amethyst, means Do Not Resuscitate (D.N.R.); red, or ruby, indicates allergies; and yellow, or amber, identifies someone at risk for falling, according the Times.
But the Joint Commission, the nation's leading hospital-accreditation agency, has cited concerns about branding patients by their end-of-life choices, or inadvertently broadcasting those choices to family and friends not involved in those choices, the newspaper said. The commission even pointed out that children sometimes unknowingly trade the wristbands like baseball cards. And some hospitals have had problems with colored bracelets that patients bring with them, such as the yellow Lance Armstrong Livestrong bracelets. Most hospitals ask patients to cut these other bands off or cover them up with tape instead, the Times said.
"You need to strike a balance between the need for patient safety and accuracy and the whole privacy concern and sensitivity and compassion for the patient, Roxanne G. Tena-Nelson, executive vice president of the Continuing Care Leadership Coalition, a group of long-term care providers in New York, told the Times.
In most places, the newspaper reported, the new bracelets replace colored ones that have been used for decades without uniformity. A survey by the Greater New York Hospital Association last year found nine different colors used to denote patients with D.N.R. orders, five to indicate allergies, and nine to highlight risks of falling, but there is still some variation.
No comments:
Post a Comment